Roxane Carr

1.4k total citations
47 papers, 1.0k citations indexed

About

Roxane Carr is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Pharmacology. According to data from OpenAlex, Roxane Carr has authored 47 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pediatrics, Perinatology and Child Health, 10 papers in Public Health, Environmental and Occupational Health and 6 papers in Pharmacology. Recurrent topics in Roxane Carr's work include Pharmaceutical studies and practices (8 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and Patient Safety and Medication Errors (3 papers). Roxane Carr is often cited by papers focused on Pharmaceutical studies and practices (8 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and Patient Safety and Medication Errors (3 papers). Roxane Carr collaborates with scholars based in Canada, United States and Australia. Roxane Carr's co-authors include Mary H. H. Ensom, Jennifer Kendrick, Helen Skouteris, Eleanor H. Wertheim, Susan J. Paxton, Dianne Duncombe, Milap C. Nahata, Peter J. Zed, John D. Mahan and Renee Robinson and has published in prestigious journals such as PEDIATRICS, Critical Care Medicine and Canadian Medical Association Journal.

In The Last Decade

Roxane Carr

43 papers receiving 952 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roxane Carr Canada 17 219 215 163 104 103 47 1.0k
Deborah L. Anderson United States 21 145 0.7× 300 1.4× 183 1.1× 177 1.7× 102 1.0× 28 1000
Giovanni Baglìo Italy 22 313 1.4× 187 0.9× 300 1.8× 56 0.5× 38 0.4× 111 1.4k
Christopher W. Jones United States 23 347 1.6× 164 0.8× 220 1.3× 118 1.1× 27 0.3× 66 1.4k
George Braitberg Australia 20 91 0.4× 113 0.5× 89 0.5× 83 0.8× 41 0.4× 78 1.0k
Karen Valentine United States 11 305 1.4× 252 1.2× 56 0.3× 30 0.3× 71 0.7× 14 1.0k
Peter M. Mullins United States 19 269 1.2× 194 0.9× 134 0.8× 134 1.3× 148 1.4× 34 1.5k
Ilene Claudius United States 17 142 0.6× 147 0.7× 180 1.1× 68 0.7× 15 0.1× 66 900
Kerry H. Cheever United States 9 98 0.4× 154 0.7× 148 0.9× 39 0.4× 41 0.4× 15 968
Christina Korownyk Canada 20 360 1.6× 111 0.5× 87 0.5× 122 1.2× 60 0.6× 103 1.9k
Philip O. Anderson United States 17 391 1.8× 293 1.4× 103 0.6× 135 1.3× 35 0.3× 98 1.1k

Countries citing papers authored by Roxane Carr

Since Specialization
Citations

This map shows the geographic impact of Roxane Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxane Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxane Carr more than expected).

Fields of papers citing papers by Roxane Carr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roxane Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxane Carr. The network helps show where Roxane Carr may publish in the future.

Co-authorship network of co-authors of Roxane Carr

This figure shows the co-authorship network connecting the top 25 collaborators of Roxane Carr. A scholar is included among the top collaborators of Roxane Carr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roxane Carr. Roxane Carr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Carr, Roxane, et al.. (2024). Describing Intravenous Extravasation Injuries in Children (DIVE2 Study). The Canadian Journal of Hospital Pharmacy. 77(2). e3525–e3525. 1 indexed citations
3.
Carr, Roxane, et al.. (2024). Effectiveness of Alprostadil for Ductal Patency. The Journal of Pediatric Pharmacology and Therapeutics. 29(1). 37–44. 1 indexed citations
4.
5.
Ensom, Mary H. H., et al.. (2019). RELATE: Relationship of limited sampling strategy and adverse effects of mycophenolate mofetil in pediatric renal transplant patients. Pediatric Transplantation. 23(2). e13355–e13355. 4 indexed citations
6.
Carr, Roxane, et al.. (2019). Analyse des outils d’évaluation des connaissances pour les patients pédiatriques participant à un programme d’éducation sur l’asthme. Journal de Pharmacie Clinique. 38(4). 187–195. 1 indexed citations
7.
West, Nicholas, et al.. (2015). A naloxone admixture to prevent opioid-induced pruritus in children: a randomized controlled trial. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 62(8). 891–900. 9 indexed citations
8.
Rainkie, Daniel, Mary H. H. Ensom, & Roxane Carr. (2015). Pediatric Assessment of Vancomycin Empiric Dosing (PAVED): a Retrospective Review. Pediatric Drugs. 17(3). 245–253. 12 indexed citations
9.
Kendrick, Jennifer, Roxane Carr, & Mary H. H. Ensom. (2015). Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing. Clinical Therapeutics. 37(9). 1897–1923. 57 indexed citations
10.
Kendrick, Jennifer, Mary H. H. Ensom, Andrew C. Steer, et al.. (2014). Standard-Dose Versus High-Dose Acyclovir in Children Treated Empirically for Encephalitis: A Retrospective Cohort Study of Its Use and Safety. Pediatric Drugs. 16(3). 229–234. 10 indexed citations
11.
Carr, Roxane, Diane Décarie, & Mary H. H. Ensom. (2014). Stability of Epinephrine at Standard Concentrations. The Canadian Journal of Hospital Pharmacy. 67(3). 197–202. 10 indexed citations
12.
Gerber, Patricia & Roxane Carr. (2013). A Pharmacokinetics Module Taught Within a Pediatrics Pharmacotherapy Course. American Journal of Pharmaceutical Education. 77(6). 126–126. 4 indexed citations
13.
Kendrick, Jennifer, et al.. (2013). Safety and Effectiveness of Dexmedetomidine in the Pediatric Intensive Care Unit (SAD–PICU). The Canadian Journal of Hospital Pharmacy. 66(1). 21–7. 35 indexed citations
14.
Ensom, Mary H. H., et al.. (2013). Compatibility and Stability of Morphine Sulphate and Naloxone Hydrochloride in 0.9% Sodium Chloride for Injection. The Canadian Journal of Hospital Pharmacy. 66(3). 163–70. 4 indexed citations
15.
Escudero, Carolina A., Roxane Carr, & Shubhayan Sanatani. (2012). The Medical Management of Pediatric Arrhythmias. Current Treatment Options in Cardiovascular Medicine. 14(5). 455–472. 7 indexed citations
16.
Daniels, Jeremy, D. Douglas Cochrane, Roxane Carr, et al.. (2011). Identification by families of pediatric adverse events and near misses overlooked by health care providers. Canadian Medical Association Journal. 184(1). 29–34. 44 indexed citations
17.
Ensom, Mary H. H., et al.. (2010). Comparison of Continuous and Intermittent IV Infusion of Vancomycin: Systematic Review. The Canadian Journal of Hospital Pharmacy. 63(5). 373–81. 8 indexed citations
18.
Carr, Roxane, Michael Wasdell, Margaret D. Weiss, et al.. (2007). Long‐term effectiveness outcome of melatonin therapy in children with treatment‐resistant circadian rhythm sleep disorders. Journal of Pineal Research. 43(4). 351–359. 84 indexed citations
19.
Skouteris, Helen, Roxane Carr, Eleanor H. Wertheim, Susan J. Paxton, & Dianne Duncombe. (2005). A prospective study of factors that lead to body dissatisfaction during pregnancy. Body Image. 2(4). 347–361. 196 indexed citations
20.
Lemos, Jane de, et al.. (1999). Paralysis in the critically ill: Intermittent bolus pancuronium compared with continuous infusion. Critical Care Medicine. 27(12). 2648–2655. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deborah L. Anderson Breakdown of academic impact, for papers by Giovanni Baglìo Breakdown of academic impact, for papers by Christopher W. Jones Breakdown of academic impact, for papers by George Braitberg Breakdown of academic impact, for papers by Karen Valentine Breakdown of academic impact, for papers by Peter M. Mullins Breakdown of academic impact, for papers by Ilene Claudius Breakdown of academic impact, for papers by Kerry H. Cheever Breakdown of academic impact, for papers by Christina Korownyk Breakdown of academic impact, for papers by Philip O. Anderson
Rankless by CCL
2026